Skip to main navigation
  • Careers
  • Contact Us
Xen 01
  • About Us
    • Management
    • Partnering
    • Board of Directors
  • Pipeline
    • Obexelimab
    • Vibecotamab
    • Plamotamab
    • Tidutamab
    • XmAb717
    • XmAb841
    • XmAb104
  • Technology
    • Bispecific Fc Domains
    • Cytotoxic Fc Domains
    • Immune Inhibitor Fc Domains
    • Xtend Fc Domains
    • Publications
  • Clinical Trials
    • Expanded Access Policy
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
      • Annual Reports
    • Analyst Coverage
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Investor FAQs
    • Contact Us
    • Email Alerts

You are here:
Home / Investors / Corporate Governance / Committee Composition

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
  • Analyst Coverage
  • Stock Information
  • Investor FAQs
  • Contact Us
  • Email Alerts

Tools

Shareholder Tools

  • Snaphot
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

Committee Composition

Independent Director Audit Committee Nominating & Corporate Governance Committee Human Capital Management & Compensation Committee Research and Development
Ellen G. Feigal, M.D. Independent Director Nominating & Corporate Governance Committee Research and Development
Kevin Gorman Independent Director Human Capital Management & Compensation Committee Research and Development
Kurt Gustafson Independent Director Audit Committee
Yujiro S. Hata Independent Director Audit Committee Nominating & Corporate Governance Committee
A. Bruce Montgomery, MD Independent Director Nominating & Corporate Governance Committee Human Capital Management & Compensation Committee Research and Development
Richard Ranieri Independent Director Human Capital Management & Compensation Committee
Dagmar Rosa-Bjorkeson Independent Director Audit Committee
= Independent Director = Chairperson = Member
Xencor © Copyright 2021 | Privacy Policy
Scroll to top